Brain oedema and Hepatic function abnormal

Summary:

Hepatic function abnormal is found among people with Brain oedema, especially for people who are male, 60+ old.

The study analyzes which people have Hepatic function abnormal with Brain oedema. It is created by eHealthMe based on reports of 47 people who have Brain oedema from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Brain oedema?

Brain oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain) is found to be associated with 957 drugs and 1,253 conditions by eHealthMe. Check the latest studies of Brain oedema.

What is Hepatic function abnormal?

Hepatic function abnormal is found to be associated with 1,438 drugs and 2,021 conditions by eHealthMe. Check the latest studies of Hepatic function abnormal.



On Aug, 08, 2026

47 people who have Brain Oedema and Hepatic Function Abnormal are studied.

Would you have Hepatic function abnormal when you have Brain oedema?

Gender of people who have Brain Oedema and experienced Hepatic Function Abnormal *:

  • female: 43.48 %
  • male: 56.52 %

Age of people who have Brain Oedema and experienced Hepatic Function Abnormal *:

  • 0-1: 10.87 %
  • 2-9: 0.0 %
  • 10-19: 2.17 %
  • 20-29: 0.0 %
  • 30-39: 13.04 %
  • 40-49: 13.04 %
  • 50-59: 10.87 %
  • 60+: 50.0 %

Common co-existing conditions for these people *:

  1. Metastases To Central Nervous System (cancer spreads to central nervous system): 8 people, 17.02%
  2. Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 7 people, 14.89%
  3. High Blood Pressure: 5 people, 10.64%
  4. Malignant Melanoma (skin cancer rises from melancytes): 4 people, 8.51%
  5. Lung Neoplasm (tumour of lung): 4 people, 8.51%
  6. Constipation: 4 people, 8.51%
  7. Renal Cell Carcinoma (a kidney cancer): 4 people, 8.51%
  8. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 6.38%
  9. Liver Disorder (liver diseases): 3 people, 6.38%
  10. Pain: 3 people, 6.38%

Common drugs taken by these people *:

  1. Opdivo: 8 people, 17.02%
  2. Sutent: 7 people, 14.89%
  3. Yervoy: 7 people, 14.89%
  4. Decadron: 5 people, 10.64%
  5. Cefazolin Sodium: 5 people, 10.64%
  6. Ketoprofen: 4 people, 8.51%
  7. Lasix: 4 people, 8.51%
  8. Mekinist: 4 people, 8.51%
  9. Nexavar: 4 people, 8.51%
  10. Tafinlar: 4 people, 8.51%

Common symptoms for these people *:

  1. Renal Impairment (severely reduced kidney function): 10 people, 21.28%
  2. Fever: 10 people, 21.28%
  3. Diarrhea: 8 people, 17.02%
  4. Malaise (a feeling of general discomfort or uneasiness): 8 people, 17.02%
  5. Secondary Adrenocortical Insufficiency (inadequate secretion of acth by the pituitary gland): 7 people, 14.89%
  6. Impetigo (contagious skin infection): 7 people, 14.89%
  7. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 7 people, 14.89%
  8. Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 7 people, 14.89%
  9. Hypopituitarism (diminished hormone secretion by the pituitary gland, causing dwarfism in children and premature aging in adults): 7 people, 14.89%
  10. Postoperative Wound Infection: 7 people, 14.89%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hepatic function abnormal?

- Check whether Hepatic function abnormal is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Hepatic function abnormal:

All the conditions that are associated with Hepatic function abnormal:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hepatic function abnormal and Brain oedema, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: